United States

SPRAVATO® treatment in Springfield, US

3 listed treatment centers serving Springfield and the surrounding area.

Clinics in Springfield

SPRAVATO® cost and insurance in Springfield

Cost and insurance questions to ask

For people in Springfield considering SPRAVATO®, the cost depends on insurance benefits, the treatment setting, and how services are billed. Both the medication and the supervised treatment visit, including monitoring, may generate charges. Ask for an estimate that includes both rather than assuming a medication quote represents the full visit.

Prior authorization is common. Your insurer may request records of earlier antidepressant trials before deciding whether to approve treatment. Ask the treatment center which records it needs, including medication names, doses, treatment dates, and how you responded. If records are held by another prescriber, arranging their transfer early may help avoid administrative delays. Authorization is not a guarantee that every charge will be paid.

Medicare coverage may fall under Part B or Part D depending on the plan and setting. Illinois Medicaid coverage also depends on the applicable program, plan, and treatment setting. The three Springfield listings currently indicate that they do not accept Medicare or Medicaid; confirm this directly, since directory information does not establish your benefits or current participation.

Manufacturer savings programs exist for eligible commercially insured patients, but not for patients using government insurance. Ask about current eligibility rules and which charges a program addresses.

Before starting, ask the center and insurer:

  • Is this location in network for both medication and treatment services?
  • Who submits prior authorization and gathers supporting records?
  • What deductible, copay, or coinsurance responsibilities could apply?
  • Are monitoring charges separate, and are additional approvals needed for continuing treatment?
  • What happens if authorization is delayed or denied?

Planning travel for treatment in Springfield

Planning visits and getting home safely

SPRAVATO® treatment requires repeated visits to a REMS-certified healthcare setting. You administer the nasal spray yourself under a healthcare provider’s direct observation; it is never supplied for home use. Springfield has three listed centers offering Spravato, but their REMS certification is not confirmed in this directory. Verify certification and current appointment availability directly before making plans.

The typical labeled treatment-resistant depression schedule starts with twice-weekly treatment during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines the schedule appropriate for you, so do not assume a fixed long-term calendar.

Allow at least two hours for monitoring after each dose, plus time for check-in, preparation, and discharge assessment. A visit may take longer depending on how you are feeling and the care team’s assessment. When requesting time off work, account for the entire appointment and transportation, not just the time spent taking the spray.

You need someone else to drive you home. You must not drive or operate machinery until the next day after a restful sleep. Arrange rides before booking, consider a backup driver, and ask the center about its discharge and pickup requirements. Discuss work involving driving or machinery when planning treatment days.

If no Springfield center is listed when you search, or the listed options cannot accommodate you, check listings in Bloomington, Peoria, or Champaign. Other Illinois listings include Chicago, Aurora, Rockford, Orland Park, and Naperville. Confirm certification, insurance participation, and scheduling before committing to travel; a directory listing alone does not verify these details.

SPRAVATO® treatment in Springfield: common questions

How can I find a certified Spravato treatment center in Springfield?

This directory lists three Springfield centers offering SPRAVATO®, but their REMS certification status is not confirmed here. Contact each center to verify that the location is currently REMS-certified and accepting patients. Also ask about evaluation requirements, appointment availability, and insurance participation. If Springfield options do not meet your needs, you can check listings in Bloomington, Peoria, or Champaign without assuming those locations have openings.

Who may be eligible for Spravato?

Spravato is FDA-approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, treatment history, and health risks to decide whether it is appropriate; a diagnosis alone does not guarantee eligibility.

Will my insurance pay for treatment in Springfield?

Coverage depends on your plan, the treatment setting, and authorization requirements. Insurers commonly request documentation of earlier antidepressant trials. Ask whether both the medication and monitoring services are covered and whether the location is in network. Medicare and Illinois Medicaid may cover treatment depending on the plan and setting, but the Springfield listings currently indicate no acceptance of either. Confirm directly with the center and insurer.

What happens during a treatment visit?

At a REMS-certified setting, you self-administer the nasal spray under direct observation. Staff monitor you for at least two hours after the dose, including checks for sedation, dissociation, breathing problems, and blood pressure increases. Discharge depends on the care team’s assessment. Arrange a driver home, and do not drive or operate machinery until the next day after a restful sleep.

What side effects and safety concerns should I discuss?

Ask your clinician about sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Review your medical history and medications with the treatment team, and report symptoms during monitoring so staff can assess them.

Can Spravato replace emergency care if I am having suicidal thoughts?

No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Its approval in this setting is for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior, alongside an oral antidepressant. Do not wait for a treatment appointment in a crisis: call or text 988, or call 911 in an emergency.

Nearby United States cities

Find a Provider